Ozel A B, McGee B, Siemieniak D, Jacobi P M, Haberichter S L, Brody L C, Mills J L, Molloy A M, Ginsburg D, Li J Z, Desch K C
Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA.
J Thromb Haemost. 2016 Sep;14(9):1888-98. doi: 10.1111/jth.13401. Epub 2016 Aug 19.
Essentials Variants at ABO, von Willebrand Factor (VWF) and 2q12 contribute to the variation in plasma in VWF. We performed a genome-wide association study of plasma VWF propeptide in 3,238 individuals. ABO, VWF and 2q12 loci had weak or no association or linkage with plasma VWFpp levels. VWF associated variants at ABO, VWF and 2q12 loci primarily affect VWF clearance rates.
Background Previous studies identified common variants at the ABO and VWF loci and unknown variants in a chromosome 2q12 linkage interval that contributed to the variation in plasma von Willebrand factor (VWF) levels. Whereas the association with ABO haplotypes can be explained by differential VWF clearance, little is known about the mechanisms underlying the association with VWF single-nucleotide polymorphisms (SNPs) or with variants in the chromosome 2 linkage interval. VWF propeptide (VWFpp) and mature VWF are encoded by the VWF gene and secreted at the same rate, but have different plasma half-lives. Therefore, comparison of VWFpp and VWF association signals can be used to assess whether the variants are primarily affecting synthesis/secretion or clearance. Methods We measured plasma VWFpp levels and performed genome-wide linkage and association studies in 3238 young and healthy individuals for whom VWF levels had been analyzed previously. Results and conclusions Common variants in an intergenic region on chromosome 7q11 were associated with VWFpp levels. We found that ABO serotype-specific SNPs were associated with VWFpp levels in the same direction as for VWF, but with a much lower effect size. Neither the association at VWF nor the linkage on chromosome 2 previously reported for VWF was observed for VWFpp. Taken together, these results suggest that the major genetic factors affecting plasma VWF levels, i.e. variants at ABO, VWF and a locus on chromosome 2, operate primarily through their effects on VWF clearance.
ABO、血管性血友病因子(VWF)及2q12位点的基本变体导致血浆VWF水平存在差异。我们对3238名个体进行了血浆VWF前体肽的全基因组关联研究。ABO、VWF和2q12位点与血浆VWFpp水平的关联较弱或无关联或连锁。ABO、VWF和2q12位点的VWF相关变体主要影响VWF清除率。
背景 既往研究确定了ABO和VWF位点的常见变体以及2号染色体12号连锁区间的未知变体,这些变体导致血浆血管性血友病因子(VWF)水平存在差异。虽然与ABO单倍型的关联可通过VWF清除差异来解释,但对于与VWF单核苷酸多态性(SNP)或2号染色体连锁区间变体相关联的潜在机制知之甚少。VWF前体肽(VWFpp)和成熟VWF由VWF基因编码并以相同速率分泌,但具有不同的血浆半衰期。因此,比较VWFpp和VWF关联信号可用于评估变体是否主要影响合成/分泌或清除。方法 我们测量了3238名年轻健康个体的血浆VWFpp水平,并进行了全基因组连锁和关联研究,这些个体之前已对VWF水平进行过分析。结果与结论 7q11染色体上一个基因间区域的常见变体与VWFpp水平相关。我们发现ABO血清型特异性SNP与VWFpp水平的关联方向与VWF相同,但效应大小要低得多。VWFpp未观察到先前报道的VWF在VWF位点的关联或2号染色体上的连锁。综上所述,这些结果表明,影响血浆VWF水平的主要遗传因素,即ABO、VWF和2号染色体上一个位点的变体,主要通过其对VWF清除率的影响发挥作用。